Cash for Biotech Slows in First Half of 2012
After coming off a hot 2011 financing year it appears that the biotech sector must be flush with cash because the amount of capital generated by private and public biotech companies slowed considerably in the first half of 2012. According to statistics compiled by BioWorld Insight drawn from BioWorld Snapshots, in the first-half of 2012 biotech fundraising generated just $7.9 billion, down 40 percent from the same period in 2011 when biotech companies raised a total of $13.3 billion.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST